Follow-up after sarcoma treatment checks for signs of recurrence and helps with recovery from treatment. The visits also give you a place to discuss symptoms, practical difficulties and worries about what comes next.[2]
On this page
Finishing treatment does not always make the next appointment feel easier. It helps to separate three questions: what the test is checking, when you will hear the result and what to do if something changes before then.
Why follow-up plans differ
For adults treated for soft tissue sarcoma, imaging recommendations take account of tumour grade, subtype and location. Some subtypes need a different approach because of where they may recur. The ESSR guidance is expert consensus informed by research, rather than proof that one schedule is optimal for everyone.[1]
Bone sarcoma follow-up also assesses the original tumour site, limb function and possible complications of reconstruction. Local radiographs may help assess both recurrence and the reconstruction. Treatment-related late effects need attention too. These considerations require a bone sarcoma plan rather than simply copying an adult soft tissue imaging schedule.[5]
A different schedule from someone else’s does not tell you whether your care is more or less thorough. The useful comparison is with the plan for your own diagnosis and treatment. The team should explain which features led to the chosen tests and intervals.
What the examination and scans are looking for
At a soft tissue sarcoma review, the clinician asks about symptoms, treatment effects and how you are coping. Examination may include looking for a new lump, swelling or lymphoedema, and assessing the operated area.[2]
Imaging the treated area
For adult soft tissue sarcoma, MRI is generally the preferred local surveillance test. For selected limb tumours, ultrasound can be an alternative, including when metal artefact limits MRI. These studies assess the original treatment region.[1]
Imaging the chest
Chest imaging checks for spread to the lungs. Depending on the plan, it may involve a chest X-ray or CT. It answers a different question from imaging of the operated limb.[2]
ESSR guidance generally favours chest CT for metastatic surveillance in adult soft tissue sarcoma. It also recommends comparing follow-up images with earlier studies, including baseline images after treatment. The team should arrange access to the earlier images, not only the written reports; copies you already hold can help.[1]
Does more scanning always mean better follow-up?
The number of scans alone does not establish the quality of follow-up. An Indian trial examined less intensive chest imaging after limb sarcoma surgery, but its findings do not make chest X-rays and CT interchangeable for every patient.[3]
More about the evidence
The randomised TOSS study at Tata Memorial Hospital compared chest-imaging strategies after limb sarcoma surgery. Its initial report found that the chest X-ray strategy met the prespecified non-inferiority criterion for overall survival against the strategy including CT. This single-centre study mixed bone and soft tissue sarcomas and used a relatively generous margin for an acceptable survival difference. Patients were told to return if symptoms developed between visits.[3]
Your team should explain why a particular test was chosen and what its result would change. If travel or appointment arrangements are difficult, raise this before altering the plan yourself. The team can help work through how the scans, consultations and results will fit together.
Follow-up includes life after treatment
Some treatment effects become apparent months or years later. Follow-up should address physical and emotional health, including persistent fatigue, sleep difficulties and anxiety. The checks needed depend on the treatments received and the person's health.[4]
A treatment summary and survivorship care plan help keep this information together. The summary should record the diagnosis, operations and other treatments. The care plan sets out follow-up and the problems to watch for. Routine primary care should continue alongside cancer follow-up.[4]
Tell the clinician if worry is disrupting sleep, work or the days between appointments. Emotional concerns belong in follow-up care alongside physical symptoms.[4] You can also be specific about the difficult part: having the scan, waiting for the report or reading it before anyone has explained it.
What to do between appointments
Contact the sarcoma team about a new lump or swelling, new pain or pain that is getting worse. Do not wait for the next scheduled review to report a new or persistent symptom.[2]
A new symptom does not automatically mean the cancer has returned. The team needs to assess whether it relates to treatment, recurrence or another health problem.[4]
A clear next step: your follow-up plan should give the next visit, any tests needed beforehand, how results will reach you and a contact route for concerns between appointments. If no appointment arrives, use that contact route to check the plan.
